Quantori, a provider of digital transformation services and technology for the life sciences and healthcare industries, has been named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026. The assessment evaluates 34 service providers globally based on market impact and vision and capability.

“We are pleased to be recognized as a Major Contender in Everest Group’s 2026 Pharmaceutical R&D IT Services PEAK Matrix® Assessment,” said Solman Rahman, Executive Vice President of Quantori. “This recognition underscores our ability to combine our deep scientific expertise with advanced AI and data capabilities. As AI-ready scientific data becomes foundational to R&D, we help clients turn GenAI and agentic AI into critical enablers that provide precise decision-making, better outcomes, and more efficient drug discovery.”

According to Everest Group, pharmaceutical companies are under growing pressure to improve R&D productivity. However, fragmented data and strict requirements for validation and oversight continue to limit the adoption of AI at scale. As a result, buyers are increasingly looking for providers that pair scientific and functional expertise with data, AI, and platform capabilities, the report finds.

This combination underpins Quantori's approach. The company supports pharmaceutical R&D through scientific informatics, data engineering, laboratory informatics, cloud and high-performance computing, with scientists and forward deployed engineers jointly developing solution accelerators and applying AI and machine learning to scientific data. Alongside these services, Quantori develops Q-Suite™, a set of AI-enabled accelerators for scientific data foundations, drug discovery, computational chemistry, and governed access to generative AI.

“R&D organizations are looking for practical ways to turn advances in AI, data, and digital technologies into meaningful scientific outcomes,” said Chris Waller, Chief Strategist at Quantori. “Our focus is on bridging science and technology to help researchers work more effectively with complex data and accelerate discovery and development.”

Learn more about Quantori’s R&D technology services and Q-Suite accelerators.

About PEAK Matrix®

The Everest Group PEAK Matrix® is a proprietary framework for assessing service providers based on their market impact and vision and capability. Market impact measures the impact created in the market, while vision and capability measures providers’ ability to successfully deliver services.

About Quantori

Quantori is a digital transformation and technology solutions company accelerating the digitization of life sciences and healthcare. Quantori transforms complex data into business value by combining deep industry knowledge, engineering excellence, and applied AI. Learn more at quantori.com and keep connected on social media X, LinkedIn, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261013326420/en/

Quantori has been recognized as a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026, highlighting its expertise in scientific data, AI, and digital transformation for pharmaceutical R&D.